Infectious Diseases Society of America

Rise and advocate! 💪 Join us this Tues. 10/21 at 7:45am for an empowering session on standing up for science and public health in today’s challenging political climate. Hear from member advocates who are making their voices heard and learn how you can too. #IDWeek2025

NEW #IDSAGuidelines! For the 2025-2026 respiratory season, IDSA strongly recommends age-appropriate COVID-19 vaccinations for immunocompromised adults and children: https://bit.ly/4nQWtmk

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://lnkd.in/eJfU8DgW

Place your bid on original artwork that tells the story of infectious disease history. Artist and ID physician Ana Velez, MD, FIDSA, FACP, donated six new paintings to support ID research. Bidding ends Oct. 21. Place your bid: https://lnkd.in/en2VTsvr

New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on the use of nirmatrelvir/ritonavir, remdesivir, and molnupiravir in adults with mild to moderate COVID-19: https://bit.ly/3W5IdtT

On IDSA’s & HIVMA’s Science Speaks blog: In the midst of threats to funding for HIV care and prevention, Andrew Trotter, MD, MPH, FIDSA, reflects on how to answer questions from patients and how to support and advocate for them. https://lnkd.in/eMpM9dEP

In children and adults with sore throat, IDSA Guidelines suggest using a clinical scoring system to determine who should be tested for Group A Streptococcal (GAS) Pharyngitis. IDSA's Group A Streptococcal (GAS) Pharyngitis guidelines have been updated: https://bit.ly/4n8OWyj

Carbapenem-resistant organisms (CRO) are a type of antibiotic-resistant bacteria that threaten human health. In OFID, authors analyzed antimicrobial susceptibility data to characterize CRO prevalence among gram-negative cultured isolates from New York City dogs and cats. https://lnkd.in/e2MQJFUZ

Are you a trainee or early career professional getting ready for #IDWeek2025? 🧭 The Early-Career Road Map is your guide to can’t-miss sessions and events, highlighted by members of the ID Training Program Directors Community of Practice and Fellows Community of Practice. Start planning your week now!: https://lnkd.in/eMh3su-R

Calling all mid- and senior-career infectious diseases and HIV specialists! Apply to the Community of Leaders 2026 program by Fri. Oct. 31 and save $255: https://bit.ly/3IdDYc6 *All applicants will be notified about their acceptance into the program on Jan. 23, 2026 Community of Leaders is designed to equip you with the skills, strategies, and connections needed to accelerate your career and amplify change initiatives. The program includes: - Exclusive curriculum crafted for ID and HIV specialists - Cohort-based learning to expand knowledge and professional networks - Hybrid format: online learning (Feb–May 2026) + in-person capstone intensive (May 5–6 in Arlington, VA) - Core themes: leadership philosophy, effective leadership behaviors, communication & conflict management, and leading change Learn more and apply by Dec. 4: https://bit.ly/3IdDYc6